FDA Clearance Tracker · K240459
Cerament Bone Void Filler
Last checked: Nov 19, 2026Latest source record: Mar 5, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 5, 2024
Substantially Equivalent
Time to decision
18 days
Received Feb 16, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240459
- Device name
- Cerament Bone Void Filler
- Applicant
- Bonesupport AB
- Applicant location
- Lund, SE
- Received
- Feb 16, 2024
- Decided
- Mar 5, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Filler, Bone Void, Calcium Compound (MQV)
- Device class
- Class II
- Regulation
- 21 CFR 888.3045
- Specialty
- Orthopedic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQV. The earliest in FDA's data is K960978, decided Jun 21, 1996.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240459
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bonesupport AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CERAMENT GBreakthrough510(k)
K234008 · Decided Mar 13, 2024 · 85 days after receipt
Device type: Filler, Bone Void, Calcium Compound Containing Single Approved Aminoglycoside (QRR) · Orthopedic Surgery
- CERAMENT GNew device typeBreakthroughDe Novo
DEN210044 · Decided May 17, 2022 · 231 days after receipt
Device type: Filler, Bone Void, Calcium Compound Containing Single Approved Aminoglycoside (QRR) · Orthopedic Surgery
K201535 · Decided Oct 16, 2020 · 130 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.